Biopharmaceutical stocks that have lagged behind the broader market may finally have their day in the sun. BofA Securities ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Amgen, a leading American biopharmaceutical company, is set to invest $200 million in a new Technology and Innovation Centre.

Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...

global head of development for Sandoz Biopharmaceuticals. Amgen company is seeking to defend its osteoporosis franchise with UCB-partnered Evenity (romosozumab), an anti-sclerostin antibody that ...

The partners are building toward a regulatory submission for Tezspire in chronic rhinosinusitis with nasal polyps in the ...

Amgen Inc., Abbvie Inc., GlaxoSmithKline ... Competition is a key aspect of market research. This Biopharmaceuticals Market report analyzes major and emerging players, assessing market share ...